CLINICAL_TRIALS
research
· 2026-03-09
Clinical Trial Update: L19IL2/TNF in Patients With Basal Cell Carcinoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating L19IL2/TNF for basal cell carcinoma is currently not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Philogen S.p.A. | Conditions: Locally Advanced Basal Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING